Breadcrumb

A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
 NEWSLatest NewsRecurrent miscarriage: what if the cause is genetic?New study paves the way to novel treatment for Triple Negative Breast CancerRI-MUHC study explores how to overcome the...
Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages
Rachel Massicotte, PhDProgram Manager1001 Decarie Blvd, Block E, 02.7211Montreal, Quebec, H4A 3J1rachel.massicotte@mail.mcgill.caTel: 514-934-1934 ext. 76302Patricia HalesProgram Assistant1001...
Success storiesThese are just a few examples of recent successes in business development at the RI-MUHC.Precision screening tool for early...
New target for cystic fibrosis drug development: Ceramides
Contact usWe welcome inquiries about Business Development Office services. Please email us: Marlies.otter@affiliate.mcgill.ca